12/18
04:05 pm
rmd
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
12/18
08:03 am
rmd
ResMed (NYSE:RMD) was given a new $260.00 price target on by analysts at Stifel Nicolaus. They now have a "hold" rating on the stock.
Low
Report
ResMed (NYSE:RMD) was given a new $260.00 price target on by analysts at Stifel Nicolaus. They now have a "hold" rating on the stock.
12/17
08:38 pm
rmd
ResMed (RMD): Revisiting Valuation After Recent Share Price Pullback [Yahoo! Finance]
Low
Report
ResMed (RMD): Revisiting Valuation After Recent Share Price Pullback [Yahoo! Finance]
12/17
07:26 am
rmd
ResMed (NYSE:RMD) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Low
Report
ResMed (NYSE:RMD) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
12/16
12:04 pm
rmd
Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 [Seeking Alpha]
Low
Report
Tandem upgraded, Zimmer, ResMed downgraded as Baird previews MedTech in 2026 [Seeking Alpha]
12/16
07:08 am
rmd
ResMed (NYSE:RMD) was given a new $275.00 price target on by analysts at Robert W. Baird.
Low
Report
ResMed (NYSE:RMD) was given a new $275.00 price target on by analysts at Robert W. Baird.
12/12
12:03 pm
rmd
ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
12/8
09:09 pm
rmd
Top 50 High-Quality Dividend Growth Stocks For December 2025 [Seeking Alpha]
Low
Report
Top 50 High-Quality Dividend Growth Stocks For December 2025 [Seeking Alpha]
12/8
09:00 am
rmd
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
Low
Report
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
12/7
12:34 am
rmd
Is It Too Late To Consider ResMed After Obesity and Sleep Apnea Headlines? [Yahoo! Finance]
Low
Report
Is It Too Late To Consider ResMed After Obesity and Sleep Apnea Headlines? [Yahoo! Finance]
12/3
04:33 pm
rmd
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/29
07:19 am
rmd
Calculating The Intrinsic Value Of ResMed Inc. (NYSE:RMD) [Yahoo! Finance]
Low
Report
Calculating The Intrinsic Value Of ResMed Inc. (NYSE:RMD) [Yahoo! Finance]
11/27
02:52 pm
rmd
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
07:12 am
rmd
Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts [Yahoo! Finance]
Low
Report
Sleep Apnea Devices Market Competitor Analysis Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts [Yahoo! Finance]
11/21
02:05 pm
rmd
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
ResMed (NYSE:RMD) had its "hold (c+)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
06:19 am
rmd
Resmed CEO Mick Farrell on new technologies, tariffs and AI [Yahoo! Finance]
Low
Report
Resmed CEO Mick Farrell on new technologies, tariffs and AI [Yahoo! Finance]
11/16
08:18 am
rmd
Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 21% gain [Yahoo! Finance]
Low
Report
Investing in ResMed (NYSE:RMD) five years ago would have delivered you a 21% gain [Yahoo! Finance]
11/15
01:21 pm
rmd
ResMed (NYSE:RMD) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
Low
Report
ResMed (NYSE:RMD) was downgraded by analysts at
Weiss Ratings from a "buy (b-)" rating to a "hold (c+)" rating.
11/10
06:21 am
rmd
22% Of This ResMed Insider's Holdings Were Sold [Yahoo! Finance]
Low
Report
22% Of This ResMed Insider's Holdings Were Sold [Yahoo! Finance]
11/3
08:03 am
rmd
ResMed (NYSE:RMD) had its price target lowered by analysts at Robert W. Baird from $320.00 to $300.00. They now have an "outperform" rating on the stock.
Low
Report
ResMed (NYSE:RMD) had its price target lowered by analysts at Robert W. Baird from $320.00 to $300.00. They now have an "outperform" rating on the stock.
10/31
11:35 am
rmd
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Low
Report
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
10/31
10:05 am
rmd
ResMed (NYSE:RMD) was given a new $305.00 price target on by analysts at Morgan Stanley.
Low
Report
ResMed (NYSE:RMD) was given a new $305.00 price target on by analysts at Morgan Stanley.
10/31
09:25 am
rmd
ResMed (NYSE:RMD) had its price target raised by analysts at KeyCorp from $298.00 to $299.00. They now have an "overweight" rating on the stock.
Low
Report
ResMed (NYSE:RMD) had its price target raised by analysts at KeyCorp from $298.00 to $299.00. They now have an "overweight" rating on the stock.
10/31
08:06 am
rmd
ResMed (NYSE:RMD) had its price target lowered by analysts at Mizuho from $310.00 to $300.00. They now have an "outperform" rating on the stock.
Medium
Report
ResMed (NYSE:RMD) had its price target lowered by analysts at Mizuho from $310.00 to $300.00. They now have an "outperform" rating on the stock.
10/30
10:21 pm
rmd
ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript [Seeking Alpha]
Low
Report
ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript [Seeking Alpha]